Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27501-27510 Newer>

The Motley Fool November 30, 2007 Timothy M. Otte	Heinz Sauces It Up The company's seemingly mundane products are providing quite spicy returns.
The Motley Fool November 30, 2007 Ron Vlieger	This Ugly Duck Turns Heads Despite its lofty status as a "global leader in filtration technology," the company fails to captivate investors.
The Motley Fool November 30, 2007 Toby Shute	A Match in the Corn Patch Two of the stronger firms in the sector, VeraSun Energy and BioEnergy, have decided that in order to ride out the market imbalance, they need to band together.
The Motley Fool November 30, 2007 Brian Lawler	MGI's Turn for "Strategic Alternatives" MGI Pharma is the latest in a growing list of drugmakers looking for someone to acquire them. The company may be a relatively more attractive takeover target than other drugmakers, because it's two lead drugs are unpartnered in the U.S.
The Motley Fool November 30, 2007 Brian Orelli	Clinical Trial Failures Don't Bother These Companies Contract research organizations, outsourcing companies hired by pharmaceutical and biotech companies to run pre-clinical tests and clinical trials for them, succeed even when drugs fail, and more work may be coming their way.
The Motley Fool November 30, 2007 Alyce Lomax	Fool on the Street: EA's Evolving Business Model Electronic Art's CFO updates analysts about exciting future opportunities for the video game industry, particularly for publishers.
The Motley Fool November 30, 2007 Toby Shute	How Deep Is Atwood Oceanics? While they've steadily risen over the last several years, Atwood's contract drilling margins remain unimpressive.
The Motley Fool November 30, 2007 Brian Orelli	Analyzing Amylin Amylin Pharmaceuticals holds its R&D day to update investors on the marketing strategy of its two diabetes products, as well as the development of its pipeline.
The Motley Fool November 30, 2007 Tim Beyers	Does Apple Need to Be Cheap? Is Apple overvalued? Read on to see why one analyst thinks it is not.
The Motley Fool November 30, 2007 Dave Mock	A Golden Opportunity in Russia Few American investors have taken note of Russian fixed-line phone company Golden Telecom. That's too bad, because Golden has been one of this year's hot stocks.
<Older 27501-27510 Newer> Return to current articles.